Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.650
+0.050 (3.12%)
At close: Sep 18, 2025, 4:00 PM EDT
1.610
-0.040 (-2.42%)
After-hours: Sep 18, 2025, 7:25 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.68 million as of September 18, 2025. Its market cap has decreased by -26.68% in one year.
Market Cap
5.68M
Enterprise Value
2.57M
1-Year Change
-26.68%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.68M, a decrease of -90.31%. That is a compound annual growth rate of -45.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 5.50M | -62.18% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |